1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (1695)
  2. Journal Article (1416)
  3. Review (80)
  4. Editorial (56)
  5. Book Section (35)
  6. Guidelines (24)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3352)
  2. Solid Tumor Oncology Division (3352)
  3. Thoracic Oncology (3352)
  4. GSK Faculty (1056)
  5. Department of Pathology and Laboratory Medicine (797)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (652)

More Groups

People
  1. Mark Kris (869)
  2. Alexander Drilon (632)
  3. Gregory Riely (599)
  4. Charles Rudin (488)
  5. Marc Ladanyi (414)
  6. Matthew Hellmann (411)

More People

Years
  1. 2025 (73)
  2. 2024 (270)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (692)
  2. Journal of Thoracic Oncology (513)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (156)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (769)
  2. Elsevier Inc. (734)
  3. American Association for Cancer Research (383)
  4. Oxford University Press (350)
  5. Nature Publishing Group (148)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing SMARCA4/STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Costa, E.; Wohlheiter, C.; Tischfield, S.; Funnell, A.; Poirier, J. T.; Villalonga, A. Q.; Sen, T.; Rudin, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Ferroptosis evasion as a therapeutic strategy in STK11/KEAP1 co-mutant lung adenocarcinoma
    Meeting Abstract

    Durani, V.; Wohlhieter, C. A.; Quintanal-Villalonga, A.; Sen, T.; Manoj, P.; Rudin, C. M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A quantitative in vivo pharmacogenomics platform uncovers biomarkers of therapy response
    Meeting Abstract

    Rosen, M.; Amar, D.; Winters, I.; Rizvi, H.; Nie, W.; Wall, G.; Petrov, D.; Winslow, M.; Rudin, C.; Juan, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Multiomic profiling of patient-derived xenografts established from patients with malignant pleural mesothelioma proposes pathways associated with poor prognosis
    Meeting Abstract

    Offin, M.; Sauter, J. L.; Egger, J. V.; deStanchina, E.; Poirier, J. T.; Zauderer, M. G.; Rudin, C.; Sen, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
    Meeting Abstract

    Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Activating canonical p53 functions in tumor-associated macrophages improves immune checkpoint blockade efficacy
    Meeting Abstract

    Ghosh, A.; Michel, J.; Venkatesh, D.; Mezzadra, R.; Dong, L.; Samaan, F.; Gomez, R.; Suek, N.; Holland, A.; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting LSD1 rescues MHC-I antigen presentation in small cell lung cancer
    Meeting Abstract

    Nguyen, M. N.; Taniguchi, H.; Chow, A.; Zhan, Y. A.; Sen, T.; Rudin, C. M.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • AKT pathway as a therapeutic target to constrain lineage plasticity leading to histological transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; Egger, J.; Qiu, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save